ResearcherFudan UniversityActive in the last 2 years
Lei Zhang
Matched on ORCID iD 0009-0007-9339-3331; OpenAlex author ID A5100434060. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 18
2021: 1 paper · 2022: none · 2023: 3 papers · 2024: none · 2025: 1 paper
Papers 5
- Pancreatic surgery is safe in elderly patients with PDAC. Co-author DOI 10.1186/s12877-025-05907-8↗
- NEDD8-Activating Enzyme Inhibitor MLN4924 Inhibits Both the Tumor Stroma and Angiogenesis in Pancreatic Cancer via Gli1 and REDD1. First author DOI 10.1007/s10620-022-07671-w↗
- Prognostic value of albumin-bilirubin score in pancreatic cancer patients after pancreatoduodenectomy with liver metastasis following radiofrequency ablation. Co-author DOI 10.3389/pore.2023.1611175↗
- Predicting Recurrence in Pancreatic Ductal Adenocarcinoma after Radical Surgery Using an AX-Unet Pancreas Segmentation Model and Dynamic Nomogram. Co-author DOI 10.3390/bioengineering10070828↗
- Identification of Key mRNAs as Prediction Models for Early Metastasis of Pancreatic Cancer Based on LASSO. Co-author DOI 10.3389/fbioe.2021.701039↗
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Wenhui Lou · 2 shared papers, 2023–2025 · strength 0.44
- Dansong Wang · 2 shared papers, 2023–2025 · strength 0.44
- Yaolin Xu · 1 shared paper, 2025 · strength 0.25
- Liang Liu · 1 shared paper, 2025 · strength 0.25
- Yueming Zhang · 1 shared paper, 2025 · strength 0.25
- Wenchuan Wu · 1 shared paper, 2025 · strength 0.25
- Jianang Li · 1 shared paper, 2023 · strength 0.19
- Xuefeng Xu · 1 shared paper, 2023 · strength 0.19
- Yefei Rong · 1 shared paper, 2023 · strength 0.19
- Wen Ming Cheng · 1 shared paper, 2023 · strength 0.19
- Weilin Mao · 1 shared paper, 2023 · strength 0.19
- Tiantao Kuang · 1 shared paper, 2023 · strength 0.19
- Haixu Ni · 1 shared paper, 2023 · strength 0.18
- Xun Li · 1 shared paper, 2023 · strength 0.18
- Qiyu Zhang · 1 shared paper, 2023 · strength 0.18
- Jian Wan · 1 shared paper, 2021 · strength 0.14
- Huilin Zheng · 1 shared paper, 2021 · strength 0.14
- Ke Xue · 1 shared paper, 2021 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.